Maria Stamelou (Μαρία Σταμέλου)

Citata da

	Tutte	Dal 2019
Citazioni	16059	11397
Indice H	60	47
i10-index	149	134

2200

1100

550

1650

20112012201320142015201620172018201920202021202220232024106 183 313 431 560 752 851 1158 1473 1655 2108 2145 2135 1858

Accesso pubblico

Visualizza tutto

94 articoli

23 articoli

Disponibili

Non disponibili

In base ai mandati di finanziamento

Coautori

Kailash BhatiaProfessor of Clinical Neurology, Institute of Neurology, UCL, Queen Square, London WC1N 3BG,Email verificata su ucl.ac.uk
Leonidas StefanisProf. Neurology-Neurobiology, Medical School, National and Kapodistrian University of AthensEmail verificata su med.uoa.gr
Amit BatlaUCL ION Queen Square LondonEmail verificata su nhs.net
Nikolaos PapagiannakisUniversity of Athens Medical School - Eginiteion HospitalEmail verificata su med.uoa.gr
Mark EdwardsProfessor of Neurology and Interface DisordersEmail verificata su kcl.ac.uk
Roberto ErroUniversitá di SalernoEmail verificata su ucl.ac.uk
Sokratis G Papageorgiou, MD, PhD, F...Associate Professor, Medical School National and Kapodistrian University of AthensEmail verificata su med.uoa.gr
Nikolaos ScarmeasNational and Kapodistrian University of AthensEmail verificata su med.uoa.gr
Christos GanosMovement Disorder Clinic, Edmond J. Safra Program in Parkinson's Disease, Neurology, UofTEmail verificata su charite.de
Gavin CharlesworthMovement Disorders Consultant, Charing Cross HospitalEmail verificata su nhs.net
Niccolò Emanuele MencacciAssistant Professor, Northwestern University, Department of NeurologyEmail verificata su northwestern.edu
Günther DeuschlDepartment of Neurology, UKSH, Christian-Albrechts University KielEmail verificata su neurologie.uni-kiel.de
Susanne KnakeEpilepsy Center Hessen, University Hospital MarburgEmail verificata su staff.uni-marburg.de
Ignacio Rubio-AgustiH. U. Vall d'Hebron; BarcelonaEmail verificata su vallhebron.cat
Nin Bajaj MA, FRCP, PhDConsultant neurologistEmail verificata su nhs.net
Jan RaethjenProfessor für Neurologie, Neurologe, KielEmail verificata su neurologie.uni-kiel.de
Anthony E LangUniversity of TorontoEmail verificata su uhnres.utoronto.ca
Dimitri M KullmannProfessor of Neurology, UCLEmail verificata su ion.ucl.ac.uk
Daniah TrabzuniSenior research fellowEmail verificata su ucl.ac.uk
Irene LitvanProfessor of Neurology, University of California San DiegoEmail verificata su ucsd.edu

Segui

Maria Stamelou (Μαρία Σταμέλου)

Prof. of Neurology, Head of Movement Disorders Dept, Hygeia Hospital, Athens, Greece; European

Email verificata su hygeia.gr - Home page

Neurology Parkinson's disease and other Movement Disorders


Titolo Ordina per citazioni Ordina per anno Ordina per titolo	Citata da Citata da	Anno
Clinical diagnosis of progressive supranuclear palsy: the movement disorder society criteria GU Höglinger, G Respondek, M Stamelou, C Kurz, KA Josephs, AE Lang, ... Movement disorders 32 (6), 853-864, 2017	1880	2017
Consensus Statement on the classification of tremors. from the task force on tremor of the International Parkinson and Movement Disorder Society KP Bhatia, P Bain, N Bajaj, RJ Elble, M Hallett, ED Louis, J Raethjen, ... Movement disorders 33 (1), 75-87, 2018	1150	2018
Past, present, and future of Parkinson's disease: A special essay on the 200th Anniversary of the Shaking Palsy JA Obeso, M Stamelou, CG Goetz, W Poewe, AE Lang, D Weintraub, ... Movement disorders 32 (9), 1264-1310, 2017	920	2017
Dopaminergic reward system: a short integrative review O Arias-Carrión, M Stamelou, E Murillo-Rodríguez, ... International archives of medicine 3 (1), 24, 2010	670	2010
Identification of common variants influencing risk of the tauopathy progressive supranuclear palsy GU Höglinger, NM Melhem, DW Dickson, PMA Sleiman, LS Wang, L Klei, ... Nature genetics 43 (7), 699-705, 2011	645	2011
The Parkinson's progression markers initiative (PPMI)–establishing a PD biomarker cohort K Marek, S Chowdhury, A Siderowf, S Lasch, CS Coffey, ... Annals of clinical and translational neurology 5 (12), 1460-1477, 2018	432	2018
The phenotypic spectrum of progressive supranuclear palsy: a retrospective multicenter study of 100 definite cases G Respondek, M Stamelou, C Kurz, LW Ferguson, A Rajput, WZ Chiu, ... Movement Disorders 29 (14), 1758-1766, 2014	383	2014
The movement disorder society criteria for the diagnosis of multiple system atrophy GK Wenning, I Stankovic, L Vignatelli, A Fanciulli, G Calandra‐Buonaura, ... Movement Disorders 37 (6), 1131-1148, 2022	375	2022
The non-motor syndrome of primary dystonia: clinical and pathophysiological implications M Stamelou, MJ Edwards, M Hallett, KP Bhatia Brain 135 (6), 1668-1681, 2012	365	2012
Reward pays the cost of noise reduction in motor and cognitive control SG Manohar, TTJ Chong, MAJ Apps, A Batla, M Stamelou, PR Jarman, ... Current Biology 25 (13), 1707-1716, 2015	345	2015
A phase 2 trial of the GSK-3 inhibitor tideglusib in progressive supranuclear palsy. DST Tolosa E, Litvan I, Höglinger GU, Burn D, Lees A, T Investigators. Movement Disorders Journal 29 (4), 470-478, 2014	326*	2014
Mutations in ANO3 cause dominant craniocervical dystonia: ion channel implicated in pathogenesis G Charlesworth, V Plagnol, KM Holmström, J Bras, UM Sheerin, E Preza, ... The American Journal of Human Genetics 91 (6), 1041-1050, 2012	295	2012
Tremor task force of the international parkinson and movement disorder society KP Bhatia, P Bain, N Bajaj, RJ Elble, M Hallett, ED Louis, J Raethjen, ... Consensus Statement on the classification of tremors. from the task force on …, 2018	242	2018
Radiological biomarkers for diagnosis in PSP: where are we and where do we need to be? JL Whitwell, GU Höglinger, A Antonini, Y Bordelon, AL Boxer, C Colosimo, ... Movement Disorders 32 (7), 955-971, 2017	229	2017
The expanding universe of disorders of the basal ganglia JA Obeso, MC Rodriguez-Oroz, M Stamelou, KP Bhatia, DJ Burn The Lancet 384 (9942), 523-531, 2014	228	2014
Parkinson’s disease in GTP cyclohydrolase 1 mutation carriers NE Mencacci, IU Isaias, MM Reich, C Ganos, V Plagnol, JM Polke, J Bras, ... Brain 137 (9), 2480-2492, 2014	216	2014
Short‐term effects of coenzyme Q₁₀ in progressive supranuclear palsy: A randomized, placebo‐controlled trial M Stamelou, A Reuss, U Pilatus, J Magerkurth, P Niklowitz, KM Eggert, ... Movement disorders: official journal of the Movement Disorder Society 23 (7 …, 2008	196	2008
AFQ056 treatment of levodopa‐induced dyskinesias: results of 2 randomized controlled trials D Berg, J Godau, C Trenkwalder, K Eggert, II Csoti, A Storch, H Huber, ... Movement Disorders 26 (7), 1243-1250, 2011	195	2011
PRRT2 gene mutations: From paroxysmal dyskinesia to episodic ataxia and hemiplegic migraine AR Gardiner, KP Bhatia, M Stamelou, RC Dale, MA Kurian, SA Schneider, ... Neurology 79 (21), 2115-2121, 2012	193	2012
Mediterranean diet adherence is related to reduced probability of prodromal Parkinson's disease MI Maraki, M Yannakoulia, M Stamelou, L Stefanis, G Xiromerisiou, ... Movement Disorders 34 (1), 48-57, 2019	185	2019

Il sistema al momento non può eseguire l'operazione. Riprova più tardi.

Articoli 1–20

Citazioni per anno

Citazioni duplicate

Citazioni unite

Aggiungi coautoriCoautori

Segui

Citata da

Coautori